LAPTM4B and neoplasm: Patients with AFP > 20 ng/ml, age>50, tumor diameter>6 cm, early recurrence (+), and advanced BCLC stage exhibited LAPTM4B up-regulation (P < 0.05; Supplementary Fig. 6A).